Ledger.Open graph →
SEC Form D · filed October 4, 2021

Rivus Pharmaceuticals, Inc

Offering
$35.0M
Sold
$34.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Shaharyar Khan · Charlottesville, VAExec · DirectorJayson Dallas · Charlottesville, VADirectorAllen Cunningham · Charlottesville, VAExec · DirectorPatrick Enright · Newport, KYDirectorFrancesco De Rubertis · BRIGHTON, MADirectorShaharyar Khan · Charlottesville, VAExec · DirectorPatrick Enright · Reading, MADirectorJayson Dallas · Charlottesville, VADirectorAllen Cunningham · Charlottesville, VAExec · DirectorFrancesco De Rubertis · ST HELIER, Y9Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗